Australian Pharmacist Pathway

OPRA® Preparation.
The New KAPS Pathway.

Prepare for the Overseas Pharmacist Readiness Assessment with a structured learning system covering biomedical sciences, medicinal chemistry, biopharmaceutics, pharmacokinetics, pharmacodynamics, pharmacology, toxicology, therapeutics, patient care and calculations.

OPRA® Formerly KAPS Biomedical Sciences Medicinal Chemistry PK / PD Pharmacology Therapeutics Patient Care MCQs
OPRA® — Overseas Pharmacist Readiness Assessment
Country Australia
Administered by Australian Pharmacy Council
Questions 120 MCQs
Exam Time 150 minutes
Format Computer-based
Highest Content Area Therapeutics & Patient Care — 45%
Important: KAPS was replaced by OPRA® from March 2025. This page keeps the KAPS URL for continuity and search traffic, but the current Australian assessment is OPRA®.
→

KAPS Has Been Replaced by OPRA®

The final KAPS examination was held in November 2024. OPRA® became the replacement assessment from March 2025 for the relevant overseas-pharmacist knowledge pathway.

View Current OPRA® Exam
01 — OPRA® Overview

The Australian Pharmacist Assessment Has Changed

KAPS was the previous knowledge assessment used in the Australian pathway. It has now been replaced by OPRA®, the Overseas Pharmacist Readiness Assessment.

120 Multiple-choice questions
150 min Examination time
45% Therapeutics & Patient Care
55 / 30 / 15 Recall / Understanding / Application
Preparation implication: The new assessment places substantial emphasis on therapeutics and patient care while still requiring a broad scientific foundation. PrepBuddy therefore combines scientific learning with application rather than treating the examination as a pure memorisation test.
02 — Australian Pharmacist Pathway

Understand the Registration Journey Before You Prepare

OPRA® is one component of a broader Australian pharmacist pathway. Passing OPRA® does not itself confer pharmacist registration.

1
Eligibility Check Determine the applicable stream
2
Knowledge Assessment OPRA® where applicable
3
Skills Assessment Outcome Where required
4
Provisional / Intern Registration Pharmacy Board pathway
5
Supervised Practice Internship / training
6
General Registration Registered pharmacist
Important: The exact pathway depends on your qualification, country, registration history and the applicable APC and Pharmacy Board pathway. Do not assume that every overseas pharmacist follows exactly the same sequence.
03 — Candidate Eligibility

Who Should Consider OPRA® Preparation?

Knowledge Stream

Internationally Educated Pharmacists

Candidates whose pharmacy qualification was completed outside the countries covered by the applicable Competency Stream rules may enter the Knowledge Stream pathway.

Indian Pharmacists

Indian B.Pharm / Pharmacy Graduates

Indian pharmacy graduates may fall within the Knowledge Stream depending on their qualification and individual circumstances. Eligibility must be confirmed through APC’s current process.

Alternative Stream

Competency Stream Candidates

Some pharmacists with qualifying education and current registration in recognised Competency Stream countries may follow a different APC assessment route, including CAOP®.

Do not choose the examination first. Choose the correct APC pathway first. The eligibility determination controls which assessment is applicable.
04 — Current Assessment

OPRA® Exam Structure

120 Questions
150 Minutes
MCQ Single best answer
Closed Book Computer-based exam

What OPRA® Assesses

  • Biomedical sciences
  • Medicinal chemistry
  • Biopharmaceutics
  • Pharmacokinetics
  • Pharmacodynamics
  • Pharmacology
  • Toxicology
  • Therapeutics
  • Patient care

What OPRA® Does Not Test

The current OPRA® examination does not examine pharmacy-practice issues specific to the Australian or New Zealand context, such as local legislation or practice standards. Those areas are addressed later in the registration journey.

Preparation distinction: Separate the OPRA® knowledge layer from the later Australian-practice and registration layer.
05 — Current OPRA® Blueprint

Study According to the Current Content Weighting

The current OPRA® examination contains five major content areas. Therapeutics and Patient Care represents the largest share.

Content Area Approximate Questions Weight
Biomedical Sciences ~24 20%
Medicinal Chemistry & Biopharmaceutics ~12 10%
Pharmacokinetics & Pharmacodynamics ~12 10%
Pharmacology & Toxicology ~18 15%
Therapeutics & Patient Care ~54 45%
Total 120 100%
Note: The question counts shown above are approximate translations of the published percentages for a 120-question examination. They should not be interpreted as a guaranteed fixed allocation in an individual examination form.
06 — How OPRA® Questions Work

Prepare for Recall, Understanding and Application

55%

Remembering / Recall

Build a reliable knowledge base for concepts, facts, principles, interactions, protocols and terminology.

30%

Comprehension / Understanding

Interpret information, compare concepts, recognise relationships and explain principles in different contexts.

15%

Application

Apply pharmaceutical knowledge to clinical and patient-related situations to reach an appropriate solution.

Know Understand Connect Apply Decide Review
07 — Biomedical Sciences

Build the Biomedical Foundation

Human Physiology

Normal body function across major systems and integration of physiological processes.

Pathophysiology

Alterations in normal physiology and mechanisms underlying disease states.

Medical Microbiology

Pathogenesis and major characteristics of bacterial, viral, fungal and parasitic infections.

Immunology

Immune responses, defence mechanisms, vaccines and vaccine-preventable disease.

Fluids & Blood

Fluid and electrolyte disorders, acid-base balance and blood-related abnormalities.

Diagnostic Understanding

Symptoms, physiological values, diagnostic tests and laboratory investigations associated with disease states.

08 — Medicinal Chemistry & Biopharmaceutics

Connect Drug Properties to Drug Performance

Physicochemical Properties

Understand how drug properties influence absorption, distribution, metabolism and excretion.

Formulation

Dosage forms, materials, delivery systems and routes of administration.

Solubility & Dissolution

Solubility, dissolution, partitioning and thermodynamic principles relevant to dosage-form performance.

Drug Stability

Degradation processes including hydrolysis and oxidation and the influence of temperature and pH.

Pharmaceutical Microbiology

Preservation, antimicrobial agents and sterilisation processes.

Drug Delivery

Oral, pulmonary, transdermal, parenteral, ophthalmic, nasal, rectal and vaginal delivery concepts.

09 — Pharmacokinetics & Pharmacodynamics

From ADME to Individualised Therapy

Drug Metabolism

Metabolic pathways, drug interactions, biotransformation, elimination and molecular mechanisms.

Pharmacokinetic Principles

Bioavailability, bioequivalence, half-life, clearance, distribution, protein binding and steady-state concepts.

Pharmacodynamic Principles

Receptors, agonists, antagonists, dose-response relationships, signal transduction and molecular pharmacology.

PK Data Interpretation

Interpret concentration-time relationships and pharmacokinetic behaviour of important medicines.

Dose Individualisation

Apply pharmacokinetic principles to dosing and monitoring in renal and hepatic dysfunction.

Loading & Steady State

Understand loading doses, time to steady state and clinically relevant dose adjustment.

10 — Pharmacology & Toxicology

Understand How Medicines Work — and When They Cause Harm

Mechanisms of Action

Drug mechanisms across major organs, systems and disease states.

Receptor Theory

Agonists, antagonists, partial agonists, dose-response curves, desensitisation and supersensitivity.

Drug Interactions

Enzyme induction, inhibition and clinically significant interaction mechanisms.

Adverse Effects

Recognise clinically important adverse effects and connect them to drug mechanisms.

Toxicology

Understand major toxic exposures, effects, recognition and principles of management.

Clinical Relevance

Convert pharmacological mechanisms into patient-centred therapeutic decisions.

11 — Highest-Weighted Area

Therapeutics & Patient Care — The Core of OPRA®

At approximately 45% of the current OPRA® content blueprint, Therapeutics and Patient Care should be the central application layer of preparation.

Cardiovascular

Apply pharmacology and clinical reasoning to common cardiovascular disease states and treatment decisions.

Endocrine & Metabolic

Diabetes, thyroid disorders and related therapeutic decision-making.

Respiratory

Respiratory conditions, drug selection, monitoring and patient care.

Infectious Diseases

Antimicrobial therapy, disease mechanisms, treatment selection, adverse effects and monitoring.

CNS & Mental Health

Neurological and psychiatric pharmacotherapy with patient-focused treatment considerations.

GI & Other Systems

Apply core therapeutic principles across common gastrointestinal and systemic conditions.

Women’s Health

Pregnancy, contraception and medicine-related considerations.

Pediatrics & Geriatrics

Special population considerations and medication-related risks.

Patient-Centred Care

Consider clinical needs, wellbeing and social-economic factors when selecting treatment.

12 — Calculations

Build Reliable Pharmacy Calculation Skills

Calculation Domains

  • Dose calculations
  • Concentration
  • Dilution
  • Ratio and proportion
  • Unit conversion
  • Infusion-related calculations
  • Compounding
  • Pharmacokinetic calculations

PrepBuddy 4-Step Method

1. Understand

Identify exactly what the question is asking.

2. Set Up

Select the correct formula and units.

3. Solve

Calculate accurately and efficiently.

4. Verify

Check units, magnitude and clinical reasonableness.

13 — Question Bank

Practice Questions That Build Readiness

Concept Questions

Test individual scientific concepts immediately after learning them.

Topic Tests

Build mastery within specific knowledge areas.

Content-Area Tests

Combine related concepts within the OPRA® blueprint.

Clinical Questions

Apply scientific knowledge to therapeutics and patient-care scenarios.

Mixed Tests

Integrate multiple content areas under timed conditions.

Weak-Area Tests

Automatically prioritise the areas where your performance shows the greatest need for remediation.

Explore OPRA® Test Series →

14 — Revision Engine

Convert Long-Term Study Into Repeatable Revision

RRT Rapid Revision Tests
Oneliners Fast recall sessions
Flashcards Active recall
Reattempt Weak-area repetition
Learn Practise Recall Retest Remediate Repeat
15 — Mock Examination

Know Your Readiness Before Exam Day

OPRA® Full Mock

  • 120-question simulation
  • 150-minute timing
  • Mixed blueprint coverage
  • Therapeutics-heavy representation
  • Scientific knowledge questions
  • Application questions
  • Detailed performance analysis

Take OPRA® Mock →

Diagnostic Assessment

  • Baseline knowledge
  • Content-area gaps
  • Therapeutic readiness
  • Calculation performance
  • Question-solving speed
  • Revision priorities
  • Repeat assessment after preparation

Take Diagnostic →

16 — Performance Analytics

Turn Your Dashboard Into Your Study Coach

Accuracy Correct response rate
Speed Time per question
Blueprint Performance by content area
Trend Improvement over time

Subject-Level Performance

Identify stronger and weaker scientific domains.

Topic-Level Performance

Detect precise areas requiring remediation.

Repeated Errors

Find concepts that continue to generate incorrect answers.

Time Analysis

Identify whether speed or knowledge is limiting performance.

Test History

Compare performance across diagnostic tests, topic tests and mocks.

Next-Step Recommendation

Convert performance data into the next most useful study action.

17 — Learning Architecture

Learn → Practice → Revise → Test → Remediate

Concept Learning

Build the pharmaceutical science foundation systematically.

Application

Connect science to therapeutics and patient-care decisions.

Question Practice

Move from recall questions to understanding and application.

Revision

Use repeated retrieval to strengthen retention.

Mock Testing

Simulate the complete OPRA® examination environment.

Remediation

Diagnose weaknesses and return to the specific learning layer that needs improvement.

18 — Daily Preparation

Make Preparation Consistent

Streak Maintain daily study
XP Reward completed learning
Badges Mark milestones
Challenges Weekly preparation targets
19 — OPRA® Study Plans

Choose the Timeline That Matches Your Starting Point

8 Weeks

Intensive

For candidates with a strong foundation who need concentrated question practice, therapeutics, revision and mocks.

12 Weeks

Balanced

Concept reinforcement, application, question practice, revision and simulation.

16 Weeks

Complete

Systematic coverage of the OPRA® blueprint with remediation and repeated testing.

24 Weeks

Foundation + OPRA®

For candidates who need substantial rebuilding of biomedical, pharmaceutical and clinical science knowledge before intensive examination preparation.

Diagnostic-first principle: Do not choose a preparation timeline based only on the calendar. Your foundation, previous preparation, available study time and diagnostic performance should determine the plan.
20 — One Prep. Many Doors.

Build One Strong Pharmacy Foundation

Large parts of the underlying pharmacy knowledge overlap across international pharmacist assessments. The destination-specific layer must then be added separately.

🇨🇦 PEBC

Canadian pharmacist certification pathway.

🇺🇸 NAPLEX

United States pharmacist licensure pathway.

🇺🇸 FPGEE

U.S. pathway for eligible foreign pharmacy graduates.

🇦🇺 OPRA®

Australian overseas pharmacist knowledge assessment.

🇮🇳 GPAT

Indian postgraduate pharmacy preparation.

🇮🇳 NIPER JEE

Advanced pharmaceutical science preparation.

PrepBuddy philosophy: Do not study six completely disconnected pharmacy syllabi. Build the core once, then attach the examination-specific, regulatory and practice-specific layer required by each destination.
21 — OPRA® / KAPS FAQ

Frequently Asked Questions

What is KAPS?

KAPS stands for Knowledge Assessment of Pharmaceutical Sciences. It was the previous Australian Pharmacy Council knowledge assessment for overseas-trained pharmacists.

Is KAPS still conducted?

No. APC replaced KAPS with the Overseas Pharmacist Readiness Assessment (OPRA®). The final KAPS examination was held in November 2024.

What is OPRA®?

OPRA® stands for Overseas Pharmacist Readiness Assessment. It is the current APC knowledge assessment used within the applicable overseas pharmacist pathway.

How many questions are in OPRA®?

The current OPRA® examination contains 120 multiple-choice questions with a single correct answer.

How long is the OPRA® exam?

Candidates receive 150 minutes, or 2 hours and 30 minutes, for the 120-question examination.

What are the major OPRA® subjects?

The current blueprint covers Biomedical Sciences; Medicinal Chemistry and Biopharmaceutics; Pharmacokinetics and Pharmacodynamics; Pharmacology and Toxicology; and Therapeutics and Patient Care.

Which OPRA® area has the highest weighting?

Therapeutics and Patient Care represents approximately 45% of the current OPRA® content blueprint.

Does OPRA® test Australian pharmacy law?

The current OPRA® exam guide states that Australian or New Zealand pharmacy-practice issues such as legislation and practice standards are not examined in OPRA®. Those areas are assessed later in the registration pathway.

Do I need to be registered as a pharmacist in India to enter the Knowledge Stream?

APC’s current Knowledge Stream eligibility information states that evidence of registration is not required for that pathway. Individual eligibility should nevertheless be confirmed through the current APC eligibility process.

Can Indian pharmacy graduates prepare for OPRA®?

Yes, Indian-trained pharmacists are among the international candidates who may pursue the Australian pathway, subject to APC’s eligibility determination for the individual’s qualification and circumstances.

Is OPRA® the same as Australian pharmacist registration?

No. OPRA® is one stage of the broader pathway. Candidates must complete the applicable skills assessment, registration, supervised-practice and other regulatory requirements.

Does a strong KAPS preparation course still have value?

Older KAPS-specific material should not be treated as the current blueprint. However, underlying pharmaceutical science knowledge remains valuable. Preparation should be remapped to the current OPRA® content areas and assessment methodology.

Can OPRA® preparation help with PEBC or NAPLEX?

The underlying pharmacy sciences overlap substantially, but the examinations assess different competencies and jurisdictions. Destination-specific preparation remains necessary.

How long should I prepare for OPRA®?

There is no universal duration. Your preparation timeline should reflect your existing pharmacy foundation, diagnostic performance, available study hours and the examination date you intend to target.

Where should I verify current OPRA® requirements?

Verify current eligibility, dates, fees, exam conditions, Skills Assessment requirements and registration requirements directly with the Australian Pharmacy Council and the Pharmacy Board of Australia.

Prepare for OPRA®.
Build the Knowledge to Practise.

Learn the science. Apply it to therapeutics. Practise the questions. Revise intelligently. Simulate the examination. Analyse your gaps. Build readiness for the next stage of your Australian pharmacist journey.

Start OPRA® Preparation →
Important information: This page is an independent educational and preparation resource. KAPS was replaced by OPRA® in 2025. Examination dates, fees, eligibility rules, assessment conditions, skills-assessment processes, registration standards and other Australian regulatory requirements can change. Always verify the current requirements directly with the Australian Pharmacy Council, the Pharmacy Board of Australia and other applicable Australian authorities before applying, paying fees, booking an exam or making registration decisions.

PrepBuddy is not affiliated with or endorsed by the Australian Pharmacy Council, Pharmacy Board of Australia, Ahpra, Department of Home Affairs or any other Australian regulatory authority.